Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: A Trial to Assess How Centanafadine Interacts With Stimulants in the Body [Phase 1]

View source ↗

Summary

A Phase 1 trial to evaluate how centanafadine interacts with stimulant medications in individuals with ADHD, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Centanafadine (centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: ADHD | Phase 1 | Status: RECRUITING